Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
AEterna Zentaris (AEZS) PT Raised to $10 at Maxim Group; Macrilen Returns to Model
-
PIPE Deals Positioned to Soar in 2017 with Trump Deregulation Gift
-
Medley Management Inc. Announces Upsizing and Pricing of $30 Million Medley LLC Public Offering of 7.25% Notes Due 2024
-
Medley Management Inc. Announces Public Offering of Medley LLC Notes Due 2024
-
Maxim Group Downgrades Teva Pharma (TEVA) to Hold
-
COPsync Announces $1.15 Million Registered Direct Offering
-
Interpace Diagnostics Announces $4.2 Million Registered Direct Offering of Common Stock
-
Interpace Diagnostics (IDXG) Discloses Private Placement of 375K Shares at $6.75/Share
-
Teva Pharma (TEVA) PT Trimmed to $49 at Maxim Group; 'Buy' Maintained
-
Maxim Group Reiterates Bullish View on Galena Biopharma (GALE) as GALE-401 is Going Pivotal in 2017
-
Prima Biomed (PBMD) PT Lowered to $7 at Maxim Group, Buy Maintained as LAG-3 + Keytruda Moves to Higher Dose
-
Milestone Scientific Inc. Announces Closing of Public Offering of Common Stock and Warrants
-
Maxim Group Starts Tsakos Energy (TNP) at Buy
-
Maxim Group Starts Nordic American Tanker Shipping Ltd. (NAT) at Sell
-
Maxim Group Starts DHT Holdings (DHT) at Buy
-
Maxim Group Starts Pyxis Tankers (PXS) at Buy
-
Interpace Diagnostics (IDXG) Enters Agreement with a Single Investor to purchase 2M Shares of Common Stock at $0.53 Per Share
-
Interpace Diagnostics Announces $1.9 Million Registered Direct Offering of Common Stock
-
Interpace Diagnostics (IDXG) Reports $2.11M Registered Direct Offering of Common Stock
-
Soligenix Announces Closing of Public Offering
-
Milestone Scientific (MLSS) Prices 2M Public Offering at $1.50 Per Share
-
Milestone Scientific Inc. Prices Public Offering of Common Stock and Warrants for Gross Proceeds of $3.0 Million
-
Milestone Scientific (MLSS) Plans Offering of Common Stock and Warrants
-
Milestone Scientific Inc. Announces Proposed Public Offering of Common Stock and Warrants
-
Brainstorm Cell Therapeutics (BCLI) Bullish View Reiterated at Maxim Group Following New Data Presentation
-
Soligenix, Inc. (SNGX) Prices 1.67M Share, 2.09M Warrant Offering
-
Soligenix, Inc. Prices $5,277,000 Public Offering and Completes Listing on Nasdaq
-
Maxim Group Maintains Bullish View on Abeona Therapeutics (ABEO) Amid Short Report
-
Notable Analyst Rating Changes 12/8: (JNPR) (HES) (COR) Upgraded; (FIT) (AZZ) (ARCX) Downgraded
-
Seanergy Maritime (SHIP) Prices 10M Common Shares, Warrants Offering for Proceeds of ~$15M
-
Seanergy Maritime Holdings Corp. Prices $15 Million Offering
-
Maxim Group Starts Xtant Medical (XTNT) at Buy
-
Cytori Therapeutics (CYTX) Scleroderma Day Offers Compelling Data - Maxim Group
-
Juno Therapeutics (JUNO) JCAR014 ASH Data Impressive But Cerebral Edema Could be a Concern - Maxim Group
-
High VCN Number at ASH Bodes Well for bluebird bio (BLUE) - Maxim Group
-
Maxim Group Maintains Bullish View on Kite Pharma (KITE) Amid First BLA for CAR-T
-
Streetinsider.com's Hot Lunchtime Reads 12/2: (FNMA) (SRPT) (GALE) (NVCN)
-
Galena Biopharma (GALE) PT Raised to $4 at Maxim Group into San Antonio Breast Cancer Symposium
-
Streetinsider.com's Hot Lunchtime Reads 12/1: (ANGI) (CAT) (BLUE) (SRPT)
-
bluebird bio (BLUE) PT Raised to $87 at Maxim Group
-
Genetic Technologies (GENE) Enters $6M ADS Direct Offering
-
Genetic Technologies Announces Offering of USD 6.0 Million of American Depository Shares
-
Maxim Group Starts Alarm.com (ALRM) at Buy
-
Notable Analyst Rating Changes 11/30: (UNH) (CE) (GS) Upgraded; (GRA) (FCX) (DLTH) Downgraded
-
Maxim Group Downgrades ManTech (MANT) to Hold
-
Maxim Group Starts SciClone Pharmaceuticals (SCLN) at Buy
-
Maxim Group Downgrades Darden Restaurants (DRI) to Hold
-
Maxim Group Downgrades Cracker Barrel (CBRL) to Hold
-
IntelliPharmaCeutics (IPCI) Rexista NDA Filing Expected, But 'Very Good News' - Maxim Group
-
Rosetta Genomics (ROSG) Prices of $5M Concurrent Registered Direct and Private Placement

